Sigma Healthcare Limited logo

Sigma Healthcare Limited (S5YA)

Market Closed
12 Dec, 20:00
XDUS XDUS
1. 62
+0.02
+1.25%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
1.6
Previous Close
Day Range
1.62 1.62
Year Range
1.49 1.93
Want to track S5YA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 74 days

Summary

S5YA closed Friday higher at €1.62, an increase of 1.25% from Thursday's close, completing a monthly increase of 5.19% or €0.08. Over the past 12 months, S5YA stock gained 3.18%.
S5YA pays dividends to its shareholders, with the most recent payment made on Sep 18, 2025. The next estimated payment will be in In 9 months on Sep 18, 2026 for a total of €0.013.
The last earnings report, released on Sep 22, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Feb 26, 2026.
Sigma Healthcare Limited has completed 2 stock splits, with the recent split occurring on Sep 10, 2009.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on ASX (AUD).

S5YA Chart

Sigma Healthcare Limited (S5YA) FAQ

What is the stock price today?

The current price is €1.62.

On which exchange is it traded?

Sigma Healthcare Limited is listed on ASX.

What is its stock symbol?

The ticker symbol is S5YA.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 26, 2026.

Has Sigma Healthcare Limited ever had a stock split?

Sigma Healthcare Limited had 2 splits and the recent split was on Sep 10, 2009.

Sigma Healthcare Limited Profile

- Industry
- Sector
- CEO
XDUS Exchange
AU000000SIG5 ISIN
United Kingdom Country
- Employees
2 Sep 2025 Last Dividend
10 Sep 2009 Last Split
- IPO Date

Overview

The Sub-Fund, constituted under the UCITS framework, is designed to provide an investment avenue that closely tracks the performance of the Bloomberg Barclays US Treasury 3-7 Year Index, which is denominated in USD. This index represents U.S. Treasury bonds with remaining maturities ranging from three years up to, but not including, seven years. The fund employs a passive index-tracking strategy, aiming to minimize the tracking error, which is the volatility of the difference between the fund's performance and that of the benchmark index. The anticipated tracking error under normal market conditions is expected to be up to 0.10%. The fund operates with the US Dollar as its reference currency, ensuring that investors are exposed to the movements in the US Treasury bond market within the specified maturity range. Additionally, for monthly hedged share classes, the Sub-Fund implements a monthly currency-hedge strategy to mitigate the impact of currency fluctuations between the share class currency and the currencies of each index component. This approach is designed to provide investors with a more stable and predictable investment outcome by reducing the risk associated with currency movements.

Products and Services

  • Passive Index-Tracking Investment Strategy:
  • This product is centered around mirroring the performance of the Bloomberg Barclays US Treasury 3-7 Year Index. Employing a passive management approach, it focuses on replication of the index's movements, thereby offering an investment solution that aims to match the returns of the designated segment of the US Treasury bond market.

  • Monthly Hedged Share Classes:
  • For investors concerned with currency risk, the Sub-Fund provides monthly hedged share classes. This feature involves a currency-hedge strategy that is revised monthly, designed to minimize the impact of currency valuation changes between the investor's share class currency and the currencies of the index's components. This service is particularly valuable for investors seeking to mitigate the potential adverse effects of currency fluctuation on their investments.

Contact Information

Address: -
Phone: -